Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
Clinical trial NCT04447911 · RECRUITING
Trial details
- NCT number
- NCT04447911
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2027-01-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.